An Act ensuring access to specialty medications
Families with members requiring specialty medications may experience reduced financial strain in obtaining these treatments.
Do you support it?
Want to know if it passes?
We'll email you when H1322 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on H1322.
You're tracking H1322
We'll email you the moment it moves.
H1322 — An Act ensuring access to specialty medications
No card. One bill, free forever — alerts when it moves.
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
In plain language
The bill ensures access to specialty medications.
This bill focuses on improving access to specialty medications for patients. It aims to address barriers that might prevent individuals from receiving necessary treatments.
What this means for you
- Families: Families with members requiring specialty medications may experience reduced financial strain in obtaining these treatments.
- Consumers: Consumers may find it easier to obtain necessary specialty medications without facing prohibitive costs.
- Healthcare: Healthcare providers will need to be aware of changes in access to specialty medications for their patients.
Summary
An Act ensuring access to specialty medications
Bill Text
- Full text Current
AI-generated reading aid from the bill's amendatory text — verify against the official bill.
This bill establishes a licensing procedure for specialty pharmacies and outlines the responsibilities of the pharmacist in charge, while also amending regulations regarding the dispensing of specialty drugs.
-
Chapter 112, Section 39K
For the purposes of this section, a “specialty pharmacy” may include any pharmacy in the commonwealth engaged in the dispensing of specialty medications as defined in section 3B of chapter 176D; provided further, that “specialty pharmacy” shall not include a mail service pharmacy.
Defines what constitutes a specialty pharmacy and explicitly excludes mail service pharmacies.
-
Chapter 112, Section 39K
The board shall establish a procedure to license specialty pharmacies, which prescribe, ship, mail, sell or dispense specialty medications in the commonwealth.
Establishes a new licensing procedure specifically for specialty pharmacies.
-
Chapter 112, Section 39K(b)(1)
A specialty pharmacy shall designate a pharmacist in charge who shall register with the board and shall be responsible for the pharmacy’s compliance with this chapter.
Requires specialty pharmacies to have a designated pharmacist in charge responsible for compliance.
-
Chapter 112, Section 39K(b)(2)
The designated pharmacist in charge shall disclose to the board the location, name and title of all principal managers and the name and applicable in-state board of registration license number of the designated pharmacist in charge, if applicable, and a letter from the board of registration of pharmacy certifying that the pharmacist in charge is in good standing with the applicable in-state board of registration.
Mandates disclosure of managerial and licensure details to the board by the pharmacist in charge.
-
Chapter 112, Section 39K(b)(3)
The designated pharmacist in charge shall certify to the board that the pharmacy maintains, at all times, a current unrestricted license, permit or registration to conduct the pharmacy in compliance with the laws and regulations of the jurisdiction in which the designated pharmacist in charge is licensed to practice.
Ensures that the pharmacy maintains a valid license and complies with regulations.
-
Chapter 112, Section 39K(b)(4)
Annually, the designated pharmacist in charge shall certify to the board that the pharmacy maintains records of all drugs dispensed to patients in the commonwealth, and that these records are readily available, upon the request of the board.
Requires annual certification of compliance and record-keeping for dispensed drugs.
-
Chapter 112, Section 39K(c)
No pharmacy or pharmacist operating outside of the state shall prescribe, ship, mail, sell, transfer or dispense drug preparations in the commonwealth unless that pharmacy has been granted a specialty license pursuant to this section.
Prohibits out-of-state pharmacies from dispensing specialty drugs in the commonwealth without a proper license.
-
Chapter 112, Section 39K(d)
The division of insurance may adopt any written policies or procedures or promulgate regulations that the division determines are necessary to implement this section.
Allows the division of insurance to create necessary regulations for the implementation of the new licensing procedure.
-
Chapter 176D, Section 3B
A carrier shall not prohibit the dispensing of specialty drugs as defined by this section that are included in its pharmaceutical drug benefits to insureds by any licensed pharmacy; provided, however, that the pharmacy is able to comply with the special handling, administration and monitoring requirements of the specialty drug.
Prevents carriers from restricting licensed pharmacies from dispensing specialty drugs covered by insurance.
-
Chapter 176D, Section 3B
A carrier shall allow any network pharmacy to provide specialty drugs if the pharmacy agrees to the same reimbursement terms and conditions.
Ensures that network pharmacies can dispense specialty drugs if they accept the same reimbursement terms.
Sponsors
- Danillo A. Sena · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 203 not signed on
Sponsors (1)
- Danillo A. Sena Democrat
Co-sponsors (0)
None.
Not signed on (203)
203 members have not signed on to this bill.
Show all 203 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does H1322 do?
- An Act ensuring access to specialty medications
- Who sponsors H1322?
- H1322 is sponsored by Danillo A. Sena (Democrat).
- What is the current status of H1322?
- This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track H1322?
- Track H1322 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on H1322
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of H1322
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →